Evidence map›Paper›PMID 17512057›Full record

ArticleJournal of neuroscience methods2007

Methodological considerations for gene expression profiling of human brain.

Mary Atz, David Walsh, Preston Cartagena, Jun Li, Simon Evans, Prabhakara Choudary, Kevin Overman, Richard Stein, Hiro Tomita, Steven Potkin and 7 more

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroscience methods, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 3 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 3 syntheses or guidelines pooled it, 116 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Pathology and Biobanking.Turk patoloji dergisi · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. NeuroTransDB: highly curated and structured transcriptomic metadata for neurodegenerative diseases.Database : the journal of biological databases and curation · 2015
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Mary AtzDepartment of Psychiatry and Human Behavior, College of Medicine, University of California, Irvine, CA, USA.
David Walsh
Preston Cartagena
Jun Li
Simon Evans
Prabhakara Choudary
Kevin Overman
Richard Stein
Hiro Tomita
Steven Potkin
Rick Myers
Stanley J Watson
E G Jones
Huda Akil
William E Bunney
Marquis P Vawter
Members of National Institute of Mental Health Conte Center and Pritzker Neuropsychiatric Disorders Research Consortium
University of California, Irvine · USUniversity of Michigan–Ann Arbor · USStanford University · USUniversity of California, Davis · US

Funding

Project 5: High-Throughput Analysis of Gene RegulationP50MH060398 · NIMH · UNIVERSITY OF CALIFORNIA-IRVINE · PI BUNNEY, WILLIAM E · 1999 to 2008
$12.7M
TISSUE SPECIFIC /INDUCIBLE REGULATION RECEPTORS /TRANSGEP01MH042251 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WATSON, STANLEY J · 1987 to 2006
$8.3M
NEUROBIOLOGICAL BRAIN ABNORMALITIES IN SCHIZOPHRENIAR01MH054844 · NIMH · UNIVERSITY OF CALIFORNIA IRVINE · PI JONES, EDWARD G · 1995 to 1999
–
NIMH NIH HHS MH42251NIMH NIH HHS MH54844NIMH NIH HHS P01 MH042251NIMH NIH HHS P50 MH060398PHS HHS P50 M60398
6 · The paper itself

Abstract

Gene expression profiles of postmortem brain tissue represent important resources for understanding neuropsychiatric illnesses. The impact(s) of quality covariables on the analysis and results of gene expression studies are important questions. This paper addressed critical variables which might affect gene expression in two brain regions. Four broad groups of quality indicators in gene expression profiling studies (clinical, tissue, RNA, and microarray quality) were identified. These quality control indicators were significantly correlated, however one quality variable did not account for the total variance in microarray gene expression. The data showed that agonal factors and low pH correlated with decreased integrity of extracted RNA in two brain regions. These three parameters also modulated the significance of alterations in mitochondrial-related genes. The average F-ratio summaries across all transcripts showed that RNA degradation from the AffyRNAdeg program accounted for higher variation than all other quality factors. Taken together, these findings confirmed prior studies, which indicated that quality parameters including RNA integrity, agonal factors, and pH are related to differences in gene expression profiles in postmortem brain. Individual candidate genes can be evaluated with these quality parameters in post hoc analysis to help strengthen the relevance to psychiatric disorders. We find that clinical, tissue, RNA, and microarray quality are all useful variables for collection and consideration in study design, analysis, and interpretation of gene expression results in human postmortem studies.

Indexed as

BrainBrain ChemistryCerebellumGene Expression ProfilingGene Expression RegulationGyrus CinguliHumansHypoxia-Ischemia, BrainMental DisordersMiddle AgedOligonucleotide Array Sequence AnalysisPostmortem ChangesRNA, MessengerRNA StabilityRNA, Messenger

Identifiers

PMID17512057
PMCPMC3835340
OpenAlexW2114453682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.